WallStreetZenWallStreetZen

NASDAQ: ITCI
Intra Cellular Therapies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ITCI

Based on 11 analysts offering 12 month price targets for Intra Cellular Therapies Inc.
Min Forecast
$74.00+0.6%
Avg Forecast
$93.55+27.17%
Max Forecast
$113.00+53.62%

Should I buy or sell ITCI stock?

Based on 11 analysts offering ratings for Intra Cellular Therapies Inc.
Strong Buy
Strong Buy
6 analysts 54.55%
Buy
3 analysts 27.27%
Hold
2 analysts 18.18%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ITCI stock forecasts and price targets.

ITCI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-06Find Out Why
lockedlocked$00.00+00.00%2024-08-21
lockedlocked$00.00+00.00%2024-08-08
lockedlocked$00.00+00.00%2024-08-08
lockedlocked$00.00+00.00%2024-08-08
Needham
Top 3%
98
BuyReiterates$100.00+35.94%2024-08-08
Mizuho
Bottom 3%
3
Strong BuyMaintains$100.00+35.94%2024-06-21
Canaccord Genuity
Bottom 5%
5
Strong BuyMaintains$113.00+53.62%2024-06-20
Bank of America
Top 17%
84
Strong BuyMaintains$91.00+23.71%2024-04-17
Baird
Top 24%
77
BuyMaintains$103.00+40.02%2024-04-17

1 of 2

Forecast return on equity

Is ITCI forecast to generate an efficient return?
Company
45.57%
Industry
37.1%
Market
58.16%
ITCI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ITCI forecast to generate an efficient return on assets?
Company
39.5%
Industry
15.92%
ITCI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ITCI earnings per share forecast

What is ITCI's earnings per share in the next 3 years based on estimates from 8 analysts?
Avg 1 year Forecast
-$0.59
Avg 2 year Forecast
$0.55
Avg 3 year Forecast
$2.55

ITCI revenue forecast

What is ITCI's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$666.2M+18.01%
Avg 2 year Forecast
$884.9M+56.74%
Avg 3 year Forecast
$1.3B+123.34%
ITCI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ITCI revenue growth forecast

How is ITCI forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
29.8%
Industry
6.42%
Market
9.32%
ITCI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ITCI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ITCI vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ITCI$73.56$93.55+27.17%Strong Buy
ELAN$14.52$18.50+27.41%Buy
LNTH$99.08$136.20+37.46%Strong Buy
CTLT$59.75$63.33+6.00%Hold
ALKS$26.99$39.71+47.14%Strong Buy
View Top Pharmaceutical Stocks

Intra Cellular Therapies Stock Forecast FAQ

Is Intra Cellular Therapies Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 11 Wall Street analysts covering (NASDAQ: ITCI) stock is to Strong Buy ITCI stock.

Out of 11 analysts, 6 (54.55%) are recommending ITCI as a Strong Buy, 3 (27.27%) are recommending ITCI as a Buy, 2 (18.18%) are recommending ITCI as a Hold, 0 (0%) are recommending ITCI as a Sell, and 0 (0%) are recommending ITCI as a Strong Sell.

If you're new to stock investing, here's how to buy Intra Cellular Therapies stock.

What is ITCI's earnings growth forecast for 2024-2026?

(NASDAQ: ITCI) Intra Cellular Therapies's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 21.17%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.98%.

Intra Cellular Therapies's earnings in 2024 is -$84,304,000.On average, 8 Wall Street analysts forecast ITCI's earnings for 2024 to be -$62,480,853, with the lowest ITCI earnings forecast at -$84,533,540, and the highest ITCI earnings forecast at -$47,550,116. On average, 7 Wall Street analysts forecast ITCI's earnings for 2025 to be $58,116,809, with the lowest ITCI earnings forecast at -$45,436,778, and the highest ITCI earnings forecast at $142,650,349.

In 2026, ITCI is forecast to generate $269,450,659 in earnings, with the lowest earnings forecast at $35,926,755 and the highest earnings forecast at $368,777,568.

What is ITCI's revenue growth forecast for 2024-2026?

(NASDAQ: ITCI) Intra Cellular Therapies's forecast annual revenue growth rate of 29.8% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.32%.

Intra Cellular Therapies's revenue in 2024 is $564,526,000.On average, 5 Wall Street analysts forecast ITCI's revenue for 2024 to be $70,392,452,428, with the lowest ITCI revenue forecast at $69,363,996,247, and the highest ITCI revenue forecast at $71,095,665,814. On average, 5 Wall Street analysts forecast ITCI's revenue for 2025 to be $93,500,435,256, with the lowest ITCI revenue forecast at $85,577,529,219, and the highest ITCI revenue forecast at $101,831,215,623.

In 2026, ITCI is forecast to generate $133,224,859,040 in revenue, with the lowest revenue forecast at $118,674,523,468 and the highest revenue forecast at $143,539,430,257.

What is ITCI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ITCI) forecast ROA is 39.5%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 15.92%.

What is ITCI's Price Target?

According to 11 Wall Street analysts that have issued a 1 year ITCI price target, the average ITCI price target is $93.55, with the highest ITCI stock price forecast at $113.00 and the lowest ITCI stock price forecast at $74.00.

On average, Wall Street analysts predict that Intra Cellular Therapies's share price could reach $93.55 by Sep 6, 2025. The average Intra Cellular Therapies stock price prediction forecasts a potential upside of 27.17% from the current ITCI share price of $73.56.

What is ITCI's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ITCI) Intra Cellular Therapies's current Earnings Per Share (EPS) is -$0.87. On average, analysts forecast that ITCI's EPS will be -$0.59 for 2024, with the lowest EPS forecast at -$0.80, and the highest EPS forecast at -$0.45. On average, analysts forecast that ITCI's EPS will be $0.55 for 2025, with the lowest EPS forecast at -$0.43, and the highest EPS forecast at $1.35. In 2026, ITCI's EPS is forecast to hit $2.55 (min: $0.34, max: $3.49).

What is ITCI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ITCI) forecast ROE is 45.57%, which is considered strong.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.